List view / Grid view

Juliana Maynard

 

article

Biomarkers In-Depth Focus 2017

Drug developers sometimes think of imaging as an emerging discipline.…

15 March 2017 | By , , , , ,

Drug developers sometimes think of imaging as an emerging discipline. But John Waterton, Paul Hockings, Juliana Maynard and Caleb Roberts explain how imaging biomarkers are transforming drug development. Francesco Gatto and Jens Nielsen, from the Chalmers University of Technology in Sweden, discuss moving towards systems biomarkers for cancer diagnosis...

article

How imaging biomarkers are transforming drug development

Drug developers sometimes think of imaging as an emerging discipline,…

15 January 2017 | By , , ,

Drug developers sometimes think of imaging as an emerging discipline, full of esoteric technologies of marginal relevance to real-world clinical drug development. In fact, the opposite is true: imaging measurements (imaging biomarkers) are used daily in drug development and in personalised medicine. They assess target engagement and receptor occupancy in…